These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31654891)

  • 81. Tiotropium in the management of paediatric and adolescent asthma: Systematic review.
    Sunther M; Marchon K; Gupta A
    Paediatr Respir Rev; 2021 Jun; 38():58-62. PubMed ID: 33243704
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Tiotropium for children and adolescents with severe asthma.
    Antonio Buendía J; Patiño DG
    J Asthma; 2023 May; 60(5):1009-1015. PubMed ID: 36047659
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
    Busse WW; Dahl R; Jenkins C; Cruz AA
    Eur Respir Rev; 2016 Mar; 25(139):54-64. PubMed ID: 26929422
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Tiotropium in asthma: From bench to bedside.
    Mansfield L; Bernstein JA
    Respir Med; 2019; 154():47-55. PubMed ID: 31212121
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium.
    Hamelmann E
    Biomed Res Int; 2018; 2018():7473690. PubMed ID: 30474042
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficacy and safety of add-on tiotropium in the management of uncontrolled asthma: a patient case series.
    Mosnaim Md G; Bizik Md BK; Wilson Pa-C C; Bensch Pa-C G
    J Asthma; 2022 Jun; 59(6):1231-1236. PubMed ID: 33974467
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pharmacokinetics and tolerability (Study 1) with particular reference to ocular safety (Study 2) of tiotropium Respimat soft mist inhaler: findings from two dose-ranging studies in healthy men.
    Feifel U; Wallenstein G; Rominger KL; Trommeshauser D; Platz J
    Int J Chron Obstruct Pulmon Dis; 2008; 3(3):397-403. PubMed ID: 18990967
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Forced Expiratory Flow (FEF
    Szefler SJ; Goldstein S; Vogelberg C; Bensch GW; Given J; Jugovic B; Engel M; Moroni-Zentgraf PM; Sigmund R; Hamelmann EH
    Pulm Ther; 2020 Dec; 6(2):151-158. PubMed ID: 32399899
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clinical predictors of asthmatics in identifying subgroup requiring long-term tiotropium add-on therapy: a real-world study.
    Cheng WC; Liao WC; Wu BR; Chen CY; Shen MF; Chen WC; Hsia TC; Tu CY; Chen CH; Hsu WH
    J Thorac Dis; 2019 Sep; 11(9):3785-3793. PubMed ID: 31656651
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The evolving role of tiotropium in asthma.
    McIvor ER; McIvor RA
    J Asthma Allergy; 2017; 10():231-236. PubMed ID: 28860828
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clinical predictors of treatment response to tiotropium add-on therapy in adult asthmatic patients: From multicenter real-world cohort data in Korea.
    Shim JS; Jin J; Kim SH; Lee T; Jang AS; Park CS; Jung JW; Kwon JW; Moon JY; Yang MS; Lee J; Choi JH; Shin YS; Kim HK; Kim S; Kim JH; Cho SH; Nam YH; Kim SH; Park SY; Hur GY; Kim SH; Park HK; Jin HJ; Lee JH; Park JW; Yoon HJ; Choi BW; Cho YJ; Kim MH; Kim TB;
    World Allergy Organ J; 2022 Dec; 15(12):100720. PubMed ID: 36438190
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Tiotropium for refractory cough in asthma via cough reflex sensitivity: A randomized, parallel, open-label trial.
    Fukumitsu K; Kanemitsu Y; Kurokawa R; Takeda N; Tajiri T; Nishiyama H; Ito K; Inoue Y; Yamamoto S; Mori Y; Fukuda S; Uemura T; Ohkubo H; Maeno K; Ito Y; Oguri T; Takemura M; Niimi A
    Ann Allergy Asthma Immunol; 2023 Jul; 131(1):59-68.e3. PubMed ID: 37030486
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma.
    Aalbers R; Park HS
    Allergy Asthma Immunol Res; 2017 Sep; 9(5):386-393. PubMed ID: 28677351
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: a real-life study.
    Cheng WC; Wu BR; Liao WC; Chen CY; Chen WC; Hsia TC; Tu CY; Chen CH; Hsu WH
    J Thorac Dis; 2018 Jun; 10(6):3661-3669. PubMed ID: 30069364
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Future perspectives of anticholinergics for the treatment of asthma in adults and children.
    Buhl R; Hamelmann E
    Ther Clin Risk Manag; 2019; 15():473-485. PubMed ID: 30936709
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cost‑effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma.
    Buendia JA; Guerrero Patiño D; Cossio-Giraldo YE
    J Asthma; 2022 Oct; 59(10):2016-2023. PubMed ID: 34551659
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Long-term safety of tiotropium delivered by Respimat
    Tan CK; Say GQ; Geake JB
    Ther Clin Risk Manag; 2016; 12():1433-1444. PubMed ID: 27703365
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cost-utility of tiotropium in patients with severe asthma.
    Buendía JA; Patiño DG
    Cost Eff Resour Alloc; 2024 Jan; 22(1):4. PubMed ID: 38238836
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effectiveness of inhalation technique assessment service for patients with Respimat® inhaler.
    Rossi V; Salimäki J; Sandler C; Airaksinen M; Kauppi P
    Pulm Pharmacol Ther; 2021 Dec; 71():102077. PubMed ID: 34534672
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Susceptibility to exacerbations in Black adults with asthma.
    Grossman NL; Doros GD; Fandino N; Fuhlbrigge AL; Pace WD; Wechsler ME; Yawn BP; Israel E
    J Asthma; 2019 Jul; 56(7):704-710. PubMed ID: 29969928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.